Market Overview

Top Narrow Based Indexes For January 15, 2013

Share:
Related PSTI
Pluristem Receives FDA Clearance to Initiate Clinical Trial of PLX-R18 to Treat Insufficient Hematopoietic Recovery Following Bone Marrow Transplant
Pluristem Therapeutics Announces Publication of Scientific Study of PLX Cells in 'Clinical Science'
Related CBPO
Mid-Afternoon Market Update: Oncomed Pharmaceuticals Slides After Poor Trial Data; Sunedison Shares Rise
Benzinga's Volume Movers

By 10:45 am, the Dow Jones Industrial Average was down 35.03 points, or 0.26%, to 13,472.29, while the broader Standard & Poor's 500 index had dropped 4.76 points, or 0.32%. The NASDAQ composite index fell 19.89 points, or 0.64%.

Some of the narrow based indexes that are still afloat in the markets are Stem Cell Stocks, which have gained 1.5%, Chinese Healthcare Stocks, up 1.1%, and Dairy Product Stocks, moving 1.0% higher as a group.

In Tickerspy's Stem Cell complex, Pluristem Therapeutics (NASDAQ: PSTI) had surged 12.7%. Pluristem Therapeutics reported that the Paul-Ehrlich-Institute has approved the company's request to expand its Phase II clinical trial in Intermittent Claudication.

The best performing Tickerspy Chinese Healthcare stock has been China Biologic Products (NASDAQ: CBPO), which was up 4.9%. China Biologic's trailing-twelve-month ROE is 30.00%.

Lifeway Foods (NASDAQ: LWAY) is today's leading Tickerspy's Dairy Product stock, gaining 6.5%. Lifeway Foods' Q4 gross sales rose around 23% to $23.0 million.

Posted-In: top Narrow Based IndexesNews Intraday Update Markets Movers

 

Related Articles (LWAY + CBPO)

View Comments and Join the Discussion!

Get Benzinga's Newsletters